Human element [ hs25 ]Position: chr16:55,240,593-55,241,874 (UCSC browser) Source: Lawrence Berkeley National Laboratory Flanking genes: IRX5 - IRX6 Timepoints: This sequence did not show observable enhancer activities at E11.5 We define a negative enhancer at this developmental stage when at least 3 transgenics were obtained and yet no reproducible pattern of expression was observed. This does not mean that this sequence is not an enhancer at another time point or a weak enhancer at this time point but below the detectable range at our level of resolution. Fasta sequence CATCCTCCAGTTTAAAAACATGTCAggataatcctgcccattgtgatgcctgtggcttct ggccacacgtgaaaggatgggcagaggtatttgaaatcagtctttctgtccccattcctt aaagcctgccacatgcaacaaacagaaaactgtgtgtgccttcatttcctaagctacttt gatgggtttctattactgacaaaaaattaaagcaagcacaagaataacagctattcctgt tgatgggtgtttatgccctttgtgcctggccctacaggtgggttaactcatcgggtcttc ccaataacctctaaggtagtcatggctacaatccccataaacaggctcagaggggctgag tacctagtctaaggctgcacagcaagcatttagcagaaacacaatttgaacccatctgtg tgaattccaagtcccaagtgttccaaccagcgtaaatgcccttggcttggaaagacgggg gctgagggcattaacctagggctcagaggcctccctccccataactattcaggccaagga tccagcctaaggcttggcgccccaacttctaaagctgggggaaggggcaggaccatgaag gaggatgggagagggggaagcatcccacagcctggtgctcacctcctgttccaactccct ccccaccctcaacaccacaatggccaatcaatacaggcttacattttatgagacaaggag tcaacttgttcaattacgggggagacagctctattctttcgtaacaagtaatctgagtag ggaaatcgatcctgagaggccccatgcacgctggctaattttatattacccttagccaat gggcgagcacagagtaatgaagttgttgttacagttgattatggggggggtggggatcaa tggagggaaaatctgaggctcagcgtcaccgctgtagcaggaagggggtgggggactcag gctgggggagcagccttcctttattcgtattccctgcccaaacacggtcagctcctgccg aaacccctaagacagaagcatctctcaggatggagacccagagactccccaccacccagg tcctgttgccccctgacagccagagtccaggaagaggccaccagagatgcaagggtggat ggaaatggggagaggtaaagcccccgtcatcacaaggctgggcttgtgaccaccacgttt cctctctgtccttgcaagtggcttttggacaggggccaggtttggcctggcagtgaaTCC TCCTTGGCATCTTGATGACTCTPrimer
|
For commercial licensing of the VISTA Enhancer Browser and its associated data please contact Virginia de la Puente (vtdelapuente@lbl.gov) at the Berkeley Lab's Innovation and Partnerships Office.